TamjeedAhmedMD

Oncology • Gallatin, TN

Physician

Join to view full profile

Dr. Ahmed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ahmed's full profile

Already have an account?

Office
225 Big Station Camp Blvd
Ste 201
Gallatin, TN 37066
Phone+1 615-451-5481

Fax+1 615-451-5486
Is this information wrong?

Education & Training

Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Tennessee Health Science Center College of MedicineClass of 2011
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

FL State Medical License 2020 - Present
TN State Medical License 2014 - 2025
NC State Medical License 2011 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

4 citations
What Oncologists Want: Identifying Challenges and Preferences on Diagnosis Data Entry to Reduce EHR-Induced Burden and Improve Clinical Data Quality.
Franck Diaz-Garelli, Roy E. Strowd, Tamjeed Ahmed, Thomas Lycan, Sean Daley
JCO Clinical Cancer Informatics. 2021-05-14
54 citations
Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries
C.M. Lanier, R.T. Hughes, Tamjeed Ahmed, M.C. LeCompte, Adrianna H. Masters
Neuro-Oncology Practice. 2019-09-20
27 citations
Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.
Marcelo Bonomi, Tamjeed Ahmed, Safoa Addo, Mitra Kooshki, Dario Palmieri
Oncology Letters. 2018-11-19

Press Mentions

CD138 Plasma Cells May Predict Brain Metastasis Recurrence Following Resection and Stereotactic RadiosurgeryOctober 7th, 2019